Clinical Trial: Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Pulmonary Hypertension Due to Lung Diseases
Study Type: OBSERVATIONAL
Official Title: AirFly: Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost
Brief Summary:
This observational real-world study aims to evaluate the longitudinal clinical outcomes of adult patients with Group 3 pulmonary hypertension (PH), associated with chronic lung diseases such as interstitial lung disease, who are treated with inhaled iloprost in routine clinical practice.Treatment options for Group 3 PH remain limited, and the use of pulmonary vasodilators is controversial due to potential worsening of gas exchange. Inhaled iloprost may provide a more selective approach by targeting well-ventilated…
Read more